Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom

Abstract

Estimates of mortality reduction and overdiagnosis were highly dependent on screening frequency, age range, and uptake, which may explain differences between some previous estimates obtained from randomised trials and from service screening.